• 1
    Alfthan H, Haglund C, Dabek J, Stenman UH. Concentrations of human choriogonadotropin, its beta-subunit, and the core fragment of the beta-subunit in serum and urine of men and nonpregnant women. Clin Chem 1992;38: 19811987.
  • 2
    Alfthan H, Schröder J, Fraser R, et al. Choriogonadotropin and its beta subunit separated by hydrophobic-interaction chromatography and quantified in serum during pregnancy by time-resolved immunofluorometric assays. Clin Chem 1988;34: 17581762.
  • 3
    Stenman UH, Alfthan H, Halila H. Determination of chorionic gonadotropin in serum of nonpregnant subjects and patients with trophoblastic cancer by time-resolved immunofluorometric assay. Tumor Biology 1985;5: 97.
  • 4
    Khazaeli MB, Buchina ES, Pattillo RA, Soong SJ, Hatch KD. Radioimmunoassay of free beta-subunit of human chorionic gonadotropin in diagnosis of high risk and low risk gestational trophoblastic disease. Am J Obstet Gynecol 1989;160: 444449.
  • 5
    Tidy JA, Rustin GJ, Newlands ES, et al. Presentation and management of choriocarcinoma after nonmolar pregnancy. Br J Obstet Gynaecol 1995;102: 715719.
  • 6
    Tomogane H, Mistry AM, Voogt JL. Late pregnancy and rat choriocarcinoma cells inhibit nocturnal prolactin surges and serotonin-induced prolactin release. Endocrinol 1992;130: 2328.
  • 7
    Bagshawe KD. From methotrexate to EMA/CO. In: SzulmanAE, BuchsbaumHJ, editor. Gestational Trophoblastic Disease. Springer-Verlag1987: 127134
  • 8
    Dobson LS, Gillespie AM, Coleman RE, Hancock BW. The presentation and management of post-partum choriocarcinoma. Br J Cancer 1999;79: 15311533.
  • 9
    Cole LA, Shahabi S, Butler SA, et al. Utility of commonly used commercial human chorionic gonadotropin immunoassays in the diagnosis and management of trophoblastic diseases. Clin Chem 2001;47: 308315.
  • 10
    Rotmensch S, Cole LA. False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations. Lancet 2000;355: 712715.
  • 11
    Bagshawe KD. Choriocarcinoma. A model for tumour markers. Acta Oncol 1992;31: 99106.